Anew Cambridge biotech will be working on a treatment using stem cells that could let children and adults with Type 1 diabetes do something their bodies currently cannot: produce their own insulin, the hormone that keeps blood sugar levels in balance. Douglas Melton, Xander University Professor of Stem Cell and Regenerative Biology and co-chair of the Department of Stem Cell & Regenerative Biology, and Peng Yi, member of the faculty of medicine at Joslin Diabetes Center, are mentioned. George King, professor of medicine at Joslin Diabetes Center, is quoted.
Trending News
Search for Babesiosis Treatment Gets a New Map
New clues to help fight tick-borne disease
Can an AI ‘Co-Scientist’ Accelerate Cancer Research?
Nearly $7 million funds agentic AI tools to assist investigations into cancer’s most pressing…
First Large-Scale Study Shows How Doctors Use AI in Medicine
Which practitioners use artificial intelligence in the clinic, and what do they ask?